Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women

被引:20
作者
Walle, T
Fagan, TC
Walle, UK
Topmiller, MJ
机构
[1] UNIV ARIZONA,COLL MED,DEPT MED,TUCSON,AZ
[2] UNIV ARIZONA,COLL MED,DEPT PHARMACOL,TUCSON,AZ
关键词
ethinyloestradiol; propranolol; metabolism; women; oral contraceptives;
D O I
10.1046/j.1365-2125.1996.03097.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The metabolism of a single 80 mg oral dose of propranolol was determined in nine young women before and after administration of ethinyloestradiol alone (EE(2)) or in combination with norethindrone (OC). 2 Whereas the total clearance of propranolol (2713 +/- 404 ml min(-1) (mean +/- s.e.mean)) was not significantly altered by either EE(2) (3365 +/- 347 ml min(-1)) or the combined OC (2905 +/- 345 ml min(-1)), significant changes in all three primary metabolic pathways were observed. 3 The clearance through side-chain oxidation decreased from 345 +/- 55 ml min(-1) to 262 +/- 33 ml min(-1) after EE(2) (P < 0.05). A similar reduction of cytochrome P450 metabolism by EE(2) has been observed for other drugs. 4 The clearance through glucuronidation increased from 364 +/- 61 ml min(-1) to 625 +/- 117 ml min(-1) after EE(2) (P < 0.01). Similar stimulation of glucuronic acid conjugation by EE(2) has also been observed for other drugs. 5 The clearance through ring oxidation increased from 697 +/- 109 ml min(-1) to 1280 +/- 162 ml min(-1) after EE(2) (P < 0.01). This observation appears to be a novel finding with EE(2) and cytochrome P450 metabolism. 6 The treatment with OC produced changes in propranolol's metabolic clearances which were qualitatively similar to those generated by EE(2).
引用
收藏
页码:305 / 309
页数:5
相关论文
共 27 条
[11]   GENDER AND ORAL-CONTRACEPTIVE STEROIDS AS DETERMINANTS OF DRUG GLUCURONIDATION - EFFECTS ON CLOFIBRIC ACID ELIMINATION [J].
MINERS, JO ;
ROBSON, RA ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (02) :240-243
[12]   EFFECTS OF ORAL-CONTRACEPTIVE STEROIDS ON ACETAMINOPHEN METABOLISM AND ELIMINATION [J].
MITCHELL, MC ;
HANEW, T ;
MEREDITH, CG ;
SCHENKER, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :48-53
[13]  
PRUEKSARITANONT T, 1993, DRUG METAB DISPOS, V21, P730
[14]   POLYMORPHIC ABILITY TO METABOLIZE PROPRANOLOL ALTERS 4-HYDROXYPROPRANOLOL LEVELS BUT NOT BETA-BLOCKADE [J].
RAGHURAM, TC ;
KOSHAKJI, RP ;
WILKINSON, GR ;
WOOD, AJJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (01) :51-56
[15]  
ROBERTS RK, 1983, J LAB CLIN MED, V101, P821
[16]   INDUCTION OF PROPRANOLOL METABOLISM IN THE HEP G2 HUMAN HEPATOMA-CELL LINE [J].
STEINER, A ;
WALLE, UK ;
WALLE, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (07) :611-614
[17]   EFFECT OF ORAL-CONTRACEPTIVES ON TRIAZOLAM, TEMAZEPAM, ALPRAZOLAM, AND LORAZEPAM KINETICS [J].
STOEHR, GP ;
KROBOTH, PD ;
JUHL, RP ;
WENDER, DB ;
PHILLIPS, JP ;
SMITH, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :683-690
[18]  
TOPMILLER MJ, 1993, CLIN PHARMACOL THER, V53, P187
[19]   PROPRANOLOL METABOLISM IN NORMAL SUBJECTS - ASSOCIATION WITH SEX STEROID-HORMONES [J].
WALLE, T ;
WALLE, T ;
MATHUR, RS ;
PALESCH, YY ;
CONRADI, EC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (02) :127-132
[20]  
WALLE T, 1987, J PHARMACOL EXP THER, V241, P928